Details for New Drug Application (NDA): 085362
✉ Email this page to a colleague
NDA 085362 describes NOVOCAIN, which is a drug marketed by Hospira and is included in two NDAs. Additional details are available on the NOVOCAIN profile page.
The generic ingredient in NOVOCAIN is procaine hydrochloride. There are seventeen drug master file entries for this compound. Additional details are available on the procaine hydrochloride profile page.
The generic ingredient in NOVOCAIN is procaine hydrochloride. There are seventeen drug master file entries for this compound. Additional details are available on the procaine hydrochloride profile page.
Summary for 085362
| Tradename: | NOVOCAIN |
| Applicant: | Hospira |
| Ingredient: | procaine hydrochloride |
| Patents: | 0 |
Medical Subject Heading (MeSH) Categories for 085362
Profile for product number 003
| Active Rx/OTC/Discontinued: | DISCN | Dosage: | INJECTABLE;INJECTION | Strength | 1% | ||||
| Approval Date: | Approved Prior to Jan 1, 1982 | TE: | RLD: | No | |||||
Profile for product number 004
| Active Rx/OTC/Discontinued: | DISCN | Dosage: | INJECTABLE;INJECTION | Strength | 2% | ||||
| Approval Date: | Approved Prior to Jan 1, 1982 | TE: | RLD: | No | |||||
Complete Access Available with Subscription
